San Francisco Sentry Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $500K | Buy |
4,444
+211
| +5% | +$23.7K | 0.26% | 109 |
|
|
2021
Q1 | $458K | Buy |
4,233
+625
| +17% | +$67.6K | 0.2% | 137 |
|
|
2020
Q4 | $387K | Sell |
3,608
-134
| -4% | -$14.4K | 0.18% | 134 |
|
|
2020
Q3 | $328K | Buy |
3,742
+10
| +0.3% | +$877 | 0.17% | 141 |
|
|
2020
Q2 | $366K | Sell |
3,732
-394
| -10% | -$38.6K | 0.19% | 117 |
|
|
2020
Q1 | $314K | Sell |
4,126
-1,105
| -21% | -$84.1K | 0.2% | 105 |
|
|
2019
Q4 | $463K | Sell |
5,231
-466
| -8% | -$41.2K | 0.21% | 113 |
|
|
2019
Q3 | $431K | Buy |
5,697
+755
| +15% | +$57.1K | 0.2% | 119 |
|
|
2019
Q2 | $360K | Sell |
4,942
-129
| -3% | -$9.4K | 0.17% | 134 |
|
|
2019
Q1 | $409K | Buy |
5,071
+175
| +4% | +$14.1K | 0.18% | 124 |
|
|
2018
Q4 | $452K | Sell |
4,896
-4
| -0.1% | -$369 | 0.21% | 94 |
|
|
2018
Q3 | $463K | Buy |
4,900
+202
| +4% | +$19.1K | 0.17% | 112 |
|
|
2018
Q2 | $435K | Buy |
4,698
+1,185
| +34% | +$110K | 0.18% | 114 |
|
|
2018
Q1 | $332K | Buy |
3,513
+127
| +4% | +$12K | 0.1% | 198 |
|
|
2017
Q4 | $327K | Buy |
3,386
+450
| +15% | +$43.5K | 0.1% | 194 |
|
|
2017
Q3 | $261K | Buy |
2,936
+277
| +10% | +$24.6K | 0.09% | 213 |
|
|
2017
Q2 | $193K | Buy |
+2,659
| New | +$193K | 0.07% | 228 |
|
|
2014
Q4 | – | Sell |
-1,511
| Closed | -$87K | – | 157 |
|
|
2014
Q3 | $87K | Buy |
1,511
+431
| +40% | +$24.8K | 0.04% | 237 |
|
|
2014
Q2 | $61K | Buy |
1,080
+1,030
| +2,060% | +$58.2K | 0.03% | 288 |
|
|
2014
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 618 |
|
|
2013
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 594 |
|
|
2013
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 603 |
|
|
2013
Q2 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 611 |
|